LOSARNIA HAMILTON: Open Payments
NPI 1376244939 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,320 in 108 payments from 17 companies in 2025. Trend: 2023 $625 · 2024 $2,364 · 2025 $2,320
Food & beverage: $2,320
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $451 |
| Otsuka America Pharmaceutical, Inc. | 11 | $254 |
| Corium, LLC | 11 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $190 |
| ABBVIE INC. | 10 | $164 |
| E.R. Squibb & Sons, L.L.C. | 9 | $162 |
| Teva Pharmaceuticals USA, Inc. | 10 | $161 |
| Axsome Therapeutics, Inc. | 6 | $153 |
| Janssen Pharmaceuticals, Inc | 5 | $118 |
| Lundbeck LLC | 5 | $108 |
Products named: INGREZZA, Azstarys, CAPLYTA, REXULTI, VRAYLAR, COBENFY, Auvelity, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
